Moreover, FOXC2 promotes chemoresistance in nasopharyngeal cancer by inducing epithelial-mesenchymal transition, while also modulating the YAP signaling pathway and enhancing glycolysis (35). This evidence concerns the gene FOXC2 and nasopharyngeal carcinoma.